Associate Director
BMS
Cambridge
Nanda Balasubramanian, PhD
Associate Director, Precision Medicine Baianlytical and Translational Sciences
Bristol Myers Squibb
Nanda brings 10+ years of experience in molecular assays, immunoassay and bioanalytical experience. As a bioanalytical lead he has supported biologics, mRNA therapeutics, ASO, Gene Therapy and CAR-T. In his current role as Associate Director at BMS he supports bioanalysis for CAR-T, gene therapy and large molecules. Prior to BMS he has held the bioanalytical lead scientist roles in increasing responsibilities at Alexion, Pfizer and Astra Zeneca. He has been part of various industry working groups including AAPS and IQ consortium. He has also co-authored reviews regarding bioanalytical strategies and approaches, specifically for new modalties. He did his postdoc at Yale University School of Medicine applying DNA repair, high-throughput screening, anti-sense oligos, nanoparticles, and gene therapy.
Disclosure information not submitted.
Perspectives on PCR-Based Cellular Kinetics and Biodistribution in Cell Therapy
Monday, November 10, 2025
10:30 AM - 11:00 AM CT